aegerion pharmaceuticals inc
Aegerion Conducts Phase III Trial For Anti-Cholesterol Drug
The clinical trial will test the efficacy of lomitapide as an adjunct treatment to reduce low-density lipoprotein cholesterol (LDL-C) in patients suffering from homozygous familial hypercholesterolemia.



